| 今开：4.77 | 昨收：4.77 |
| 最高：4.86 | 最低：4.441 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：5.9090718E7 |
Eagle制药(EGRX)02-07 22:25
$Eagle制药(EGRX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-005210 Act: 34 Size: 91 KB 网页链接查看全文
Eagle制药(EGRX)03-01 05:55
$Eagle制药(EGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-023198 Size: 7 KB 网页链接查看全文
Eagle制药(EGRX)03-01 09:25
$Eagle制药(EGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-006003 Size: 6 KB 网页链接查看全文
Eagle制药(EGRX)03-09 05:55
$Eagle制药(EGRX)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001104659-24-032458 Act: 34 Size: 334 KB 网页链接查看全文
Eagle制药(EGRX)01-27 00:55
$Eagle制药(EGRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-004272 Act: 34 Size: 13 KB 网页链接查看全文
Eagle制药(EGRX)03-19 08:45
$Eagle制药(EGRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-070394 Act: 34 Size: 84 KB 网页链接查看全文
Eagle制药(EGRX)03-18 20:05
$Eagle制药(EGRX)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001104659-24-035268 Act: 34 Size: 33 KB 网页链接查看全文
Eagle制药(EGRX)02-07 06:15
$Eagle制药(EGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-002831 Size: 5 KB 网页链接查看全文
Eagle制药(EGRX)02-13 21:55
$Eagle制药(EGRX)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-017472 Act: 34 Size: 202 KB 网页链接查看全文
Eagle制药(EGRX)03-01 20:45
$Eagle制药(EGRX)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-24-029624 Act: 34 Size: 274 KB 网页链接查看全文
$Eagle制药(EGRX)$ 8-K Current report, items 3.01, 7.01, and 9.01 Accession Number: 0001104659-24-046776 Act: 34 Size: 262 KB 网页链接
$Eagle制药(EGRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-070394 Act: 34 Size: 84 KB 网页链接
$Eagle制药(EGRX)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001104659-24-035268 Act: 34 Size: 33 KB 网页链接
$Eagle制药(EGRX)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001104659-24-032458 Act: 34 Size: 334 KB 网页链接
$Eagle制药(EGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-023945 Size: 5 KB 网页链接
$Eagle制药(EGRX)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-24-029624 Act: 34 Size: 274 KB 网页链接
$Eagle制药(EGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-006003 Size: 6 KB 网页链接
$Eagle制药(EGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-023198 Size: 7 KB 网页链接
$Eagle制药(EGRX)$ 8-K Current report, item 2.05 Accession Number: 0001104659-24-029090 Act: 34 Size: 208 KB 网页链接
$Eagle制药(EGRX)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-024047 Act: 34 Size: 44 KB 网页链接